## Histological Classification of Nasopharyngeal Carcinoma **Key Point:** Non-keratinizing undifferentiated squamous cell carcinoma (WHO Type III, formerly Schmincke carcinoma) is the predominant histological type globally, accounting for ~95% of NPC cases, particularly in endemic regions. ### EBV Association **High-Yield:** The undifferentiated type shows the strongest and most consistent association with EBV infection: - EBV DNA detected in nearly 100% of undifferentiated NPC - EBV present in tumor cells (not just surrounding stroma) - Latent EBV infection is a critical pathogenic factor ### WHO Classification of NPC Histology | Histological Type | EBV Association | Geographic Distribution | Frequency | | --- | --- | --- | --- | | Keratinizing SCC | Weak | North Africa, Middle East | 10–15% | | Non-keratinizing (undifferentiated) | Very strong (>95%) | Southeast Asia, Southern China | 80–95% | | Non-keratinizing (differentiated) | Strong | Variable | 5–10% | | Adenocarcinoma | Weak | Rare globally | <1% | | Small cell carcinoma | Absent | Very rare | <1% | **Clinical Pearl:** In endemic areas (Southeast Asia, Southern China), the undifferentiated type predominates; in non-endemic regions, keratinizing SCC is relatively more common, though still less frequent overall. ### Mechanism of EBV Oncogenesis 1. EBV infects nasopharyngeal epithelium 2. Latent infection with expression of EBNA-1, LMP-1, LMP-2 3. LMP-1 acts as constitutive CD40 analog → NF-κB activation 4. Dysregulation of apoptosis and cell cycle progression 5. Accumulation of additional genetic hits (TP53, CDKN2A mutations) **Mnemonic:** **UNKEMPT** = **U**ndifferentiated **N**asopharyngeal carcinoma, **K**eratinizing (less common), **E**BV (strong link to undifferentiated), **M**ost common type, **P**redominant in endemic zones, **T**umor biology driven by latent EBV [cite:Harrison 21e Ch 109] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.